We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Software Platform Extends MS Analysis to Include Small Molecules

By HospiMedica staff writers
Posted on 05 Jun 2008
A new software platform has extended its mass spectrometry (MS) franchise to include small molecules in addition to protein analysis.

Although MS manufacturers are selling an increasing number of instruments for small molecule analysis, the bioinformatics aspect has been mostly underdeveloped. More...
The new software program, SmileMS, offers robust, machine-independent software for the analysis of MS spectra from small molecules; a modern and dynamic user interface enabling users to seamlessly navigate through and share their results; and an open database of small molecule spectra allowing users to add both public and private data, enrich their proper search domain, and more share the database with other users.

SmileMS is a unique software platform for the identification and analysis of small molecules by liquid chromatography-mass spectrometry techniques. Developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland), in collaboration with the Swiss Institute of Bioinformatics (SIB; Geneva, Switzerland) and Prof. Denis Hochstrasser's group at Geneva University Hospitals (Geneva, Switzerland), SmileMS targets a growing need a growing need for efficient and automatable processes for routine daily analysis of small molecules.

Prof. Denis Hochstrasser said, "My lab has been thoroughly working with the GeneBio team for more than a year now and we are very happy with the quality of the results SmileMS is producing in its early version. The tool by far surpasses other tools we have tested for both the quality of its results, its user-friendliness, and most importantly its extreme flexibility; using the same tool and databases with different separation methods and instruments as well as sharing the results amongst different users through Web access show great promise for routine clinical application.”


Related Links:
Geneva University Hospitals
Geneva Bioinformatics
Swiss Institute of Bioinformatics

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.